B+
Bull case
25%
Probability
Target price
$21.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
GLUE
Monte Rosa TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Monte Rosa has multiple Phase 2 entry points, a potential H2 2026 MRT-8102 readout, and substantial reported runway, creating meaningful clinical optionality. [#SEC-8K-2026-05-07]
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +7.1.
What can break
Clinical readouts and Phase 2 starts may be delayed or produce weaker efficacy, safety, or biomarker results than expected.
Momentum
2
Value
41
Sentiment
74
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $15.50 · Bull $21.00 · Bear $10.00Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $28.50
Why
Momentum2 · Δ7d +0.2
Value41 · Δ7d 0.0
Sentiment74 · Δ7d +7.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +7.1.
Contradictions & invalidation
- • Clinical readouts and Phase 2 starts may be delayed or produce weaker efficacy, safety, or biomarker results than expected.
- • Peer comparability and analyst coverage are limited, increasing valuation uncertainty.
- • The company remains clinical-stage with limited commercial support.
Catalyst clock
2026-09-30
MRT-2359 Phase 2 initiation
Lead driver: Sentiment · See AI snapshot
Momentum
2
9% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
-0.7
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-8.2
Sentiment
74
62% active weight
Current posture
7d trendImproving
Δ7d
+7.1
Δ21d
+9.0
Why this grade
Composite grade C. Momentum 2.0 / Value 41.2 / Sentiment 74.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$15.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$10.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.31B
Beta
1.61
Shares Out
85.31M
P/E (TTM)
57.5
P/S (TTM)
5.17
P/FCF (TTM)
6.47
Rev YoY
-61.3%
EPS YoY
+185.8%
Gross Margin
+71.7%
Op Margin
-633.0%
Net Debt
-$337.91M
Current Ratio
10.58
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data